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Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, FranceAbstractPostoperative peritonitis (POP) is a common surgical complication
after bariatric surgery (BS). We assessed the importance of positive
fungal cultures in these cases of POP admitted to the intensive care
unit. Clinical features and outcome were compared in 25 (41%)
Candida-positive patients (6 (22%) ﬂuconazole-resistant Candida
glabrata) and 36 patients without Candida infection. Candida
infections were more commonly isolated in late-onset peritonitis
and were often associated with multidrug-resistant bacteria. Risk
factors for intensive care unit mortality (19.6%) were diabetes
and superobesity. Candida infections, including ﬂuconazole-
resistant strains, are common in POP after BS. These data
encourage the empirical use of a broad-spectrum antifungal agent.
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ment of morbid obesity [1]. Anastomotic leaks are one of the
most frequent postoperative surgical complications, leading to
admission to the intensive care unit [2]. These patients
combine many conventional risk factors for fungal infection,
such as prior surgery, broad-spectrum antibiotic use and
severity of illness [3]. To assess the characteristics of fungal
infections during postoperative peritonitis (POP) after BS, we
compared the clinical features of patients with Candida-positive
samples with those without Candida.
Between 1997 and 2012, all consecutive patients with a
diagnosis of POP were prospectively analysed. Our microbi-
ologic procedures have been previously described [4]. The
mycology department performed fungus identiﬁcation and
susceptibility testing. According to European Committee on
Antimicrobial Susceptibility Testing guidelines, Candida glabrata
strains were considered to be not susceptible to ﬂuconazole
(http://www.eucast.org/ﬁleadmin/src/media/PDFs/EUCAST_
ﬁles/AFST/Antifungal_breakpoints_v_7.0.pdf).
Empirical antibiotic therapy, initiated at the time of reoper-
ation, combined piperacillin/tazobactam or imipenem with
amikacin and vancomycin possibly associated with antifungal
therapy on the basis of presumed risk factors [5,6].
Demographic data, underlying diseases and clinical and
surgical characteristics were collected at admission to the
intensive care unit. Severity on the day of reoperation was
assessed using the Acute Physiology and Chronic Health Eval-
uation II score [7]. The risk of fungal infection was assessed by
the peritonitis score [6]. Therapeutic features and prognosis
were recorded.
Results are expressed as mean (standard deviation) or
numbers (proportions). Candida-positive and -negative patients
were compared by the Student t and chi-square tests or by the
Fisher exact test when required. Risk factors for death were
assessed by univariate analysis followed by multivariate logistic
regression analysis. Odds ratios and 95% conﬁdence intervals
were calculated. Sensitivity, speciﬁcity, positive predictive value
(PPV), negative predictive value (NPV) and overall accuracy
(OA) were calculated for the diagnostic tests. A value of p
<0.05 was considered signiﬁcant.
Sixty-one patients were analysed (Table 1). A total of 27
fungi were cultured from peritoneal ﬂuid in 25 (41%) patients
(2 (8%) patients had fungaemia). Direct fungal examination of
peritoneal ﬂuid had a sensitivity of 20%, a speciﬁcity of 100%, a
PPV of 100%, a NPV of 64% and an OA of 69%. Fungi were
more frequently cultured from late-onset peritonitis (>day 15)
(44% vs. 37.5% in early reoperation, p 0.03) and were associ-
ated with multidrug-resistant bacteria (Table 1). Susceptibility
testing was available for 22 organisms, revealing six (27%)Clin Microbiol Infect 2015; 21: 853.e1–853.e3
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TABLE 1. Clinical and microbiologic characteristics and outcome of 61 patients admitted for postoperative peritonitis with or
without fungal peritonitis
Characteristic Total (n [ 61) Positive fungal culture (n [ 25) Negative fungal culture (n [ 36) p
Age (years), mean (SD) 43 (12) 44 (12) 43 (11) 0.67
Female gender, n (%) 43 (70) 18 (72) 25 (69) 0.83
BMI (kg/m2), mean (SD) 48 (11) 49 (12) 48 (10) 0.71
Superobese, n (%) 15 (16) 7 (28) 8 (22) 0.61
Diabetes, n (%) 23 (38) 9 (36) 14 (38) 1
Initial surgery
Sleeve gastrectomy, n (%) 14 (23) 7 (28) 7 (19) 0.54
Gastric bypass, n (%) 32 (52) 13 (52) 19 (53) 1
Reoperation before ICU admission, n (%) 26 (43) 10 (40) 16 (46) 0.79
Antibiotics before ICU, n (%) 33 (54) 16 (64) 17 (46) 0.20
Interval between initial surgery and
diagnosis of POP, mean (SD)
14 (14) 17 (16) 12 (13) 0.27
Cause of postoperative peritonitis
Gastrointestinal perforation, n (%) 25 (41) 9 (36) 16 (46)
Anastomotic leak, n (%) 38 (62) 12 (48) 16 (46) 0.69
Abscess, n (%) 12 (20) 5 (20) 7 (20)
APACHE II score, mean (SD) 18 (6) 20 (7) 17 (8) 0.08
Total no. of cultured bacteria 140 49 91
Monomicrobial samples, n (%) 8 (13) 3 (12) 5 (14) 0.83
Multidrug-resistant bacteria, n (%) 14 (10) 9 (18) 5 (5) 0.03
No. of fungi 27 27 — —
Candida albicans, n (%) 15 15 (56) — —
Candida glabrata, n (%) 6 6 (22) — —
Candida tropicalis, n (%) 2 2 (7) — —
Candida lusitaniae, n (%) 1 1 (4) — —
Outcome
Duration of mechanical ventilation in
survivors (days), mean (SD)
15 (12) 12 (12) 0.5
Length of ICU stay in survivors
(days), mean (SD)
21 (14) 21 (19) 0.95
Mortality, n (%) 7 (28) 5 (14) 0.20
APACHE, Acute Physiology and Chronic Health Evaluation; BMI, body mass index; ICU, intensive care unit; POP, postoperative peritonitis; SOFA, Sequential Organ Failure
Assessment.





(n [ 49) p
Women, n (%) 7 (58) 36 (73) 0.31
Age, years, mean (SD) 47 (12) 42 (12) 0.22
BMI (kg/m2) 54 (10) 46 (11) 0.04
Superobese, n (%) 6 (50) 9 (18) 0.022
Hypertension, n (%) 8 (67) 18 (37) 0.06
Diabetes, n (%) 8 (67) 15 (31) 0.02
Sleep apnoea syndrome, n (%) 4 (33) 10 (20) 0.35
Bypass, n (%) 7 (58) 25 (51) 0.66
Early intra-abdominal infection, n (%) 10 (83) 42 (86) 0.84
Antibiotics before ICU, n (%) 7 (58) 26 (53) 0.75
APACHE II score, mean (SD) 25 (7) 16 (7) 0.0003
SOFA score, mean (SD) 11 (4) 6.7 (3) 0.0009
Vasoactive agents, n (%) 10 (83) 31 (63) 0.19
Positive blood culture, n (%) 2 (17) 9 (18) 0.89
Peritoneal microorganisms, mean (SD) 2.1 (1) 2.7 (1) 0.08
Presence of Gram-negative bacilli, n (%) 6 (50) 33 (67) 0.27
Presence of Gram-positive cocci, n (%) 9 (75) 40 (82) 0.61
Presence of fungi, n (%) 7 (58) 18 (37) 0.18
Fungi reported on direct examination, n (%) 1 (8) 5 (10) 0.78
Adequate empirical antibiotic therapy, n (%) 10 (83) 36 (73) 0.70
Adequate empirical antifungal therapy, n (%) 11 (92) 42 (86) 0.59
APACHE, Acute Physiology and Chronic Health Evaluation; BMI, body mass index;
ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment.
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colonisation rate was 5% for the overall cohort and 4% in
Candida-positive patients. No risk factors for fungal peritonitis
were identiﬁed (Table 1). A grade C level of the peritonitis
score (three or more risk factors) had 80% sensitivity, 72%
NPV, 36% speciﬁcity, 42% PPV and 54% OA. Forty-one patients
(67%) received empirical antifungal therapy (ﬂuconazole n = 31,
caspofungin n = 10), including 21 (58%) of 36 Candida-negative
patients. All patients with a positive direct examination for fungi
received empirical antifungal therapy. Four Candida-positive
patients (16%) received inadequate therapy (ﬂuconazole against
C. glabrata). Empirical antifungal therapy remained unchanged in
13 cases (de-escalation in 3 cases and escalation in 3 cases). The
mean duration of antifungal therapy was 18 ± 4 days (range
10–24 days). The mortality and morbidity rates were not
different between the two groups (Table 1). Risk factors of
death in univariate analysis are presented in Table 2. In multi-
variate analysis, diabetes (odds ratio 4.53, 95% conﬁdence in-
terval 1.03–17.64, p 0.044) and superobese patients (body
mass index >50 kg/m2) (odds ratio 4.38, 95% conﬁdence in-
terval 1.08–17.8, p 0.039) were signiﬁcant risk factors for
mortality.
A high rate of Candida-positive peritoneal ﬂuid cultures and
high rates of ﬂuconazole-resistant strains were observed in thisClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecttypical population of complicated BS patients. The presence of
fungi in surgical samples was difﬁcult to predict. Mortality and
morbidity rates were similar in both groups. The presence of
fungi in peritoneal ﬂuid is not surprising in patients with pro-
longed infections [8]. However, our fungal culture rates
appeared to be higher than those reported in several studies ofious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 853.e1–853.e3
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ported the presence of Candida in 31% to 37% of cases [4,12].
Postoperative changes in host microbiota could be proposed
as a driving force for the emergence of Candida, as fungal
colonization has been reported in the excluded and functional
parts of the stomach of patients who have previously under-
gone gastric bypass surgery [13]. The clinical relevance of
positive fungal samples in surgical patients remains a subject of
debate. Untreated Candida colonization is usually rapidly
cleared from the peritoneal space. In some cases, true infec-
tion occurs, with intra-abdominal abscesses, persistent growth
on repeated surgeries and a risk of dissemination [14]. The
progressive colonization of extraperitoneal sites can only be
documented by repeated cultures [15]. However, the vast
majority of these patients are referred from surgical wards
without surveillance programmes. Our data demonstrated the
poor predictive value of clinical criteria. The peritonitis score
has a very low PPV, which could be explained by the over-
representation of two criteria in our population (70% of
women and 100% of upper gastrointestinal surgery). Fungal
biomarkers such as β–D-glucan could be of interest to identify
those patients who really need to be treated [16]. Several
articles suggest a link between fungal cultures and poorer
outcome [9,10,17], especially with gastroduodenal perfora-
tions [9,17]. The high rate of ﬂuconazole-resistant strains
previously reported [18] supports the empirical use of echi-
nocandins due to the potential risk of increased mortality in
the case of delayed therapy [19]. However, no clinical study
has ever assessed the need to treat Candida peritonitis. Our
cohort is obviously underpowered to draw any conclusions on
mortality issues (258 patients would be necessary to conclude
on the role of Candida). Several limitations of our study have
to be stressed. This single-centre survey performed in a
reference centre may not provide a reliable picture of
complicated BS cases. The global prevalence of fungi in these
patients might be underestimated, as our analysis was limited
to the ﬁrst reoperation.
In summary, Candida strains are frequently cultured from
surgical samples in POP after BS. The high rates of ﬂuconazole-
resistant strains and the failure to identify any risk factors for
positive fungal samples justify providing empirical broad-
spectrum antifungal treatment.Transparency declarationAll authors report no conﬂicts of interest relevant to this
article.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InReferences[1] DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med
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